673475-74-6

Basic information

• Product Name: 3-Amino-4-cyclopropyl-1H-pyrazole
• Synonyms: 3-Amino-4-cyclopropyl-1H-pyrazole;4-Cyclopropyl-1H-pyrazol-3-amine;4-cyclopropyl-1H-pyrazol-5-amine;3-aMino-4-cyclopropyl-1H-pyrazol
• CAS NO: 673475-74-6
• Molecular Formula: C₆H₉N₃
• Molecular Weight: 123.16
• Product Categories: API intermediates
• Mol File: 673475-74-6.mol

Chemical Properties

• Boiling Point: 320.668 °C at 760 mmHg
• Flash Point: 173.723 °C
• Appearance: /
• Density: 1.349
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.694
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 3-Amino-4-cyclopropyl-1H-pyrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-4-cyclopropyl-1H-pyrazole(673475-74-6)
• EPA Substance Registry System: 3-Amino-4-cyclopropyl-1H-pyrazole(673475-74-6)

Safety Data

• Hazardous Substances Data: 673475-74-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
3-Amino-4-cyclopropyl-1H-pyrazole is used as a key intermediate in the synthesis of pharmaceuticals for its potential biological activity. It contributes to the development of new drugs with therapeutic benefits.
Used in Drug Research and Development:
In the pharmaceutical industry, 3-Amino-4-cyclopropyl-1H-pyrazole is utilized as a research compound for the exploration and development of novel drug candidates. Its presence in drug discovery pipelines underscores its importance in advancing medical treatments.
Used in Treatment of Diseases:
3-Amino-4-cyclopropyl-1H-pyrazole has been studied for its potential therapeutic applications in the treatment of various diseases, including cancer and inflammatory conditions. Its biological activity makes it a promising candidate for further research and potential clinical use.
Used in Agrochemicals:
Although not explicitly mentioned in the provided materials, given its common presence in agrochemicals, 3-Amino-4-cyclopropyl-1H-pyrazole may also be used in the development of agrochemical products, potentially for pest control or as a component in fertilizers, due to its chemical properties and reactivity.

InChI:InChI=1/C6H9N3/c7-6-5(3-8-9-6)4-1-2-4/h3-4H,1-2H2,(H3,7,8,9)

Upstream product

• 6542-60-5 2-cyclopropylacetonitrile 
• 256376-79-1 2-cyclopropyl-3-oxo-propionitrile 
• 109-94-4 formic acid ethyl ester 
• 64-19-7 acetic acid 

Relevant articles and documents

TRISUBSTITUTED PYRAZOLO [1,5-A] PYRIMIDINE COMPOUNDS AS CDK7 INHIBITORS

Compounds having activity as cancer agents are provided. The compounds have the following structure (I) or a pharmaceutically acceptable salts, stereoisomers, tautomers, thereof, wherein R1, R2, R3 and L are as defined herein. This disclosure provides methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds, and methods for treating a CDK7-dependent disease (e.g., cancer).

INDOLE AHR INHIBITORS AND USES THEREOF

The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.

6,7,8,9-TETRAHYDRO-5H-1,4,7,10A-TETRAAZA-CYCLOHEPT[F]INDENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESSES FOR PREPARING THEM

The present invention relates to compounds defined by formula (I), wherein the groups X, Y, W and R 1 to R 4 are defined as in claim 1, possessing valuable pharmacological activity. Particularly the compounds are agonists of the 5-HT2C receptor, and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this receptor, such as metabolic and CNS-related disorders

7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors

7-Aminopyrazolo[1,5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered. Investigation of structure-activity relationships of the pyrazolo[1,5-a]pyrimidine nucleus led to a series of 6-(4-N,N′-diphenyl) ureas that potently inhibited

PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

PYRAZOLOPYRIMIDINES AS CYCLIN-DEPENDENT KINASE INHIBITORS

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

PYRAZOLOPYRIMIDINES AND THE USE THEREOF FOR CONTROLLING HARMFUL ORGANISMS

The invention relates to novel pyrazolopyrimidines of formula (I) wherein R1, R2, R3, X1 and X2 have the designations cited in the description, to a method for producing said substances, and to the use of the same for controlling harmful organisms. The invention also relates to novel intermediates of formulae (II), (V) and (VI), and to methods for producing the same.